Ani Pharmaceuticals Inc (NASDAQ:ANIP)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Keeps a healthy share of every dollar it sells.
- Revenue
- $978.4M
- Net income
- $105.8M
- Net margin
- 10.8%
Little or no net debt.
- Total debt
- $330.3M
- Cash
- $360.2M
- Net debt / EBITDA
- -0.12x
Comfortably covers what is due within a year.
- Current assets
- $825.4M
- Current liabilities
- $283.7M
- Current ratio
- 2.91
The business funds itself from operations.
- Operating cash flow
- $189.5M
- Free cash flow
- $159.4M
- FCF margin
- 16.3%
Not funding itself by issuing shares.
- Shares outstanding
- 21.2M
- Share growth (1y)
- 6.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ANIP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 266.04 M | 237.46 M | 247.06 M | 227.81 M | 211.37 M | 197.12 M |
| Revenue Growth (YoY) | 25.87 % | 20.46 % | 29.64 % | 53.58 % | 53.12 % | 43.43 % |
| Cost of Revenue | 100.16 M | 114.50 M | 9.50 M | 116.02 M | 74.61 M | 73.04 M |
| Gross Profit | 165.89 M | 122.96 M | 237.56 M | 111.79 M | 136.76 M | 124.08 M |
| SG&A Expense | 91.66 M | 73.66 M | 82.79 M | 76.66 M | 81.77 M | 76.53 M |
| R&D Expense | 14.75 M | 10.60 M | 12.26 M | 12.30 M | 16.54 M | 10.56 M |
| Operating Expenses | 125.43 M | 84.25 M | 189.38 M | 88.96 M | 122.86 M | 97.89 M |
| Operating Income | 40.46 M | 38.71 M | 48.17 M | 22.83 M | 13.89 M | 26.19 M |
| Pretax Income | 37.10 M | 40.22 M | 31.48 M | 33.80 M | 10.53 M | 19.99 M |
| Tax Provision | 12.39 M | 10.73 M | 3.99 M | 7.18 M | 1.98 M | 4.31 M |
| Net Income | 24.71 M | 29.49 M | 27.49 M | 24.13 M | 8.55 M | 15.68 M |
| EPS (Basic) | 1.09 | 1.31 | 1.24 | 1.19 | 0.37 | 0.70 |
| EPS (Diluted) | 1.05 | 1.28 | 1.17 | 1.13 | 0.36 | 0.69 |
| Shares Outstanding | 21.16 M | 20.91 M | 20.05 M | 20.07 M | 19.83 M | 19.61 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.